IRF1 and tuberculosis: In order to investigate the mechanisms of these responses, we used nebulized rIFN-γ1b in eleven drug-sensitive tuberculosis patients, and found an increase in signaling molecules STAT-1, IRF-1 and IRF-9 [14].